We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-6.50 | -0.41% | 1,583.50 | 1,582.50 | 1,583.00 | 1,595.50 | 1,580.00 | 1,593.00 | 5,931,081 | 16:35:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.22 | 65.15B |
Date | Subject | Author | Discuss |
---|---|---|---|
12/8/2022 08:25 | Did dame Emma give Jope a ring yet, or too busy doing high teas, rowing regattas and polio parties? | purplepelmets | |
12/8/2022 08:23 | UnastubsI thought bond prices would fall as inflation rises? | ch1ck | |
12/8/2022 08:22 | The weakest of rallys fading fast. | spoole5 | |
12/8/2022 08:22 | Google figures updated daily. PE ratio 11.02 (about the same as many banks) Dividend Yield 6.58% | netcurtains | |
12/8/2022 08:21 | If the drug was not sold in the US how it there a case to answer?CONFUSED | ch1ck | |
12/8/2022 08:19 | yep absolutely | wall street trader | |
12/8/2022 08:19 | Agree this is time to top up as issue is not a problem. Looking good price to fill ya boots. | halfpenny | |
12/8/2022 08:19 | #30460 Completion of GSK Share Consolidation "expected dividend for 2023 converts to 56.25p per new ordinary share." .5625/14.60 = 3.85% so for £20k means £770pa not £1000 pa. £11.25 would be the share price where 56.25p earnt me £1000 a year. I can get 3.2% on a one year fixed bond right now and that's only going to improve going forward. GSK not the place for income right now, capital appreciation also in doubt. therefore i wait. | unastubbs | |
12/8/2022 08:12 | Leave it in Compounding in a few years you will be getting a lot more than £1000 a year.No brainier | tfergi | |
12/8/2022 08:09 | Let's be honest here this isn't going out of business or dropping the dividend Invest £20K at this level and you will get over a thousand quid a year for the rest of your life - a no brainier for me | wall street trader | |
12/8/2022 08:04 | Grabbed some more this morning to help with the average. Still need 1585 to be back to square one but more confident today than yesterday. | tuftymatt | |
12/8/2022 07:46 | Has been for the last two years just closer to the first cases. It will rumble on for years too of course | daneswooddynamo | |
12/8/2022 07:46 | sure. haha. tbh looking to invest and hold. hence trying to get the best price possible. think there could be an opportunity ahead which better reflects all the known risks. | unastubbs | |
12/8/2022 07:44 | Nothing new in the statement just as there was nothing new over the past few days. All the info is out there | spoole5 | |
12/8/2022 07:42 | unastubbs: Sounds like you should have bought some yesterday and now you're having a bit of a temper fit. | netcurtains | |
12/8/2022 07:34 | obviously the ADR improvement last night gives some indication of where this is going today, but to my mind the statement changes nothing. the fact of the litigation exists, with potential to blow up in every country where zantac has been sold. until this is dealt with entirely there will be a huge cloud of uncertainty and despond over GSK (and HLN & SAN). i personally am happy to be on the sidelines for now, would consider an entry point south of £12. | unastubbs | |
12/8/2022 07:31 | How much are we expecting it to rise on open? | netcurtains | |
12/8/2022 07:26 | A well explained statement that makes it clear what the company thinks of this and will do about it. Bound to recover today on the back of that but by how much remains to be seen. | tuftymatt | |
12/8/2022 07:20 | NIce to see GSK reference the same study I highlighted yesterday (plus others). On an individual basis it will be almost impossible to prove anyones illness was directly caused by Zantac. Litigation is a minefield though. | dr biotech | |
12/8/2022 07:11 | Am reassured by statement but will hold back unless as stated previously dips further over coming weeks Mind if up 30% as some have predicted will be happy to take some profit For now just happy to have got one right | jubberjim | |
12/8/2022 07:06 | Well that will,so the trick expect this to be up 10% today and get nearer 30% in the next couple of months | wall street trader | |
12/8/2022 07:01 | Statement out | spoole5 | |
12/8/2022 06:58 | FT Alphaville's take, published during trading hours yesterday: | zho | |
12/8/2022 06:33 | Let's see what today brings.Sanofi's share price chart followed GSK'S very closely until they recovered in the afternoon to be only just over 3% down.GSK's share price flattened around the 1400p mark mostly. | redbaron10 | |
12/8/2022 00:23 | Relentless selling by hedge funds who would not dump stock like this and in this quantity without inside knowledge and good reason. First trial just days away. PI's do not move share prices... | justiceforthemany |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions